RealClearHealth - Opinion, News, Analysis, Video and Polls

Friday, June 5

Set this view as default? Yes No
Set this view as default? Yes No
This Was the Moment the COVID-19 Experts Betrayed Us
Robby Soave, Reason
ALS Breakthroughs Are Within Reach
Andrea Goodman, RealClearHealth
FDA Advances Psychedelics, but More Is Needed
Peter Pitts, Wash Examiner
Why Medicare and Medicaid Fraud Won’t Go Away
David Goldhill, City Journal
Affordable to Buy, Costly to Use
Thom Walsh, The American Prospect
No Workable Single-Payer Plan After 40 Years
Veronique de Rugy, Reason
The FDA’s AI Double-Talk
Keith J. Dreyer & James M. Hillis, RealClearHealth
Faster FDA Approvals Will Save Lives and Trillions of $$$
Staff, Unleash Prosperity
Detours on the Road to Medical Advances
Steven Kritz, Brownstone Institute
How the COVID Genome Reveals Its Lab Origins
Paul D. Thacker, Disinformation Chron
Sign up for our free morning newsletter: Daily Newsletters | RealClearHealth

Follow the Science

COVID-19: They’ve Learned Nothing
Roger Bate, Brownstone Institute
Good Lifestyle Habits Affects Higher Work Engagement
Juri Matsuoka, et al., NIH
Why Every GLP-1 Prescription Needs an Exit
Matthew Holt, The Health Care Blog
Deregulation Can Make Medications Cheaper
Charles Hooper, Incidental Insights

Research & Analysis

Solving the Alzheimer's Challenge
Burns, et al., Alzheimer's Policy Working Group
Holding Health Insurers Accountable
Ryan Long, Paragon
Combatting Academic Fraud
Vince Bielski, RealClearInvestigations
Prior Authorization: AHIP’s Commitments
Jackson Hammond, RealClearHealth

More From Real Clear

The Latest Research from RealClear’s Journal of the Academy of Public Health
Article Image
Estimating the Importance of Change in Patient-Reported Outcome Measures
Patient-reported outcome measures (PROMs) are essential for capturing the patient’s perspective on their functioning and well-being...
Article Image
Restoring Regulatory Fairness and Reclaiming Biomedical Leadership: ALS, Rare Disease Regulation, and the Future of Regenerative Medicine
Amyotrophic Lateral Sclerosis (ALS) remains one of the most difficult neurodegenerative diseases in modern medicine. Despite major advanc...
These Are Where the Medicaid 'Cuts' Are Going.
The Value, Science, & Policies Surrounding Vaccines
What Doesn't Kill You ...
Was Trump's Operation Warp Speed a Success?

This Was the Moment the COVID-19 Experts Betrayed Us

Robby Soave, Reason

Remember when pro-lockdown public health experts said protesting was OK if it was against racism? Read More

ALS Breakthroughs Are Within Reach

Andrea Goodman, RealClearHealth

This ALS Awareness Month, lawmakers and regulators face a pivotal moment in the fight against ALS. For the first time in history - following... Read More

FDA Advances Psychedelics, but More Is Needed

Peter Pitts, Wash Examiner

In response to Trump's recent executive order, the FDA announced plans to expedite the review of certain psychedelic medicines for mental... Read More

Why Medicare and Medicaid Fraud Won’t Go Away

David Goldhill, City Journal

The programs operate as open-ended entitlements, making it hard to separate outright scams from aggressive but routine billing. Read More

Affordable to Buy, Costly to Use

Thom Walsh, The American Prospect

Health care affordability depends on access to care and the true cost of care, not just insurance premiums. Read More

No Workable Single-Payer Plan After 40 Years

Veronique de Rugy, Reason

Vermont passed single-payer legislation in 2011 and abandoned the plan after three years of failure. Why? Read More

The FDA’s AI Double-Talk

Keith J. Dreyer & James M. Hillis, RealClearHealth

It’s budget season in Washington, and the Trump Administration’s FY2027 FDA request contains a welcome idea: a Clinical Trial... Read More

Faster FDA Approvals Will Save Lives and Trillions of $$$

Staff, Unleash Prosperity

We’re happy to report that Fox News covered the latest Unleash Prosperity Now study on how speeding up drug approvals by opening... Read More

Detours on the Road to Medical Advances

Steven Kritz, Brownstone Institute

Given that life expectancy in this country has stagnated over the past 12-15 years, it’s past time that we take look at what... Read More

How the COVID Genome Reveals Its Lab Origins

Paul D. Thacker, Disinformation Chron

The origin of COVID-19 has sparked relentless debate since 2020. But if we truly follow the science, the evidence for a lab-based beginning... Read More

Follow the Science

COVID-19: They’ve Learned Nothing

Roger Bate, Brownstone Institute

The UK Covid-19 Inquiry has released the political chapters of its long-awaited report. After nearly three years, the conclusion is clear. Read More

Good Lifestyle Habits Affects Higher Work Engagement

Juri Matsuoka, et al., NIH

Organizations are encouraged to support employees in developing good lifestyle habits to increase work engagement. Read More

Why Every GLP-1 Prescription Needs an Exit

Matthew Holt, The Health Care Blog

I’ve seen clients start GLP-1 medications full of hope—and stop them feeling betrayed by their own biology. Read More

Deregulation Can Make Medications Cheaper

Charles Hooper, Incidental Insights

If the FDA policed only safety, not efficacy, the result would be more innovation at lower cost. Read More

Research & Analysis

Solving the Alzheimer's Challenge

Burns, et al., Alzheimer's Policy Working Group

The Alzheimer’s Policy Working Group is a 501(c)(3) organization that unites frontline clinicians from specialty and primary care to... Read More

Holding Health Insurers Accountable

Ryan Long, Paragon

On Thursday, January 22, the House Energy and Commerce Committee and the House Ways and Means Committee will each hold a hearing with some of... Read More

Combatting Academic Fraud

Vince Bielski, RealClearInvestigations

This is the fourth part of a series on the crisis in academic research and publishing. Read the first three parts here, here and here. By... Read More

Prior Authorization: AHIP’s Commitments

Jackson Hammond, RealClearHealth

Introduction In August, AHIP, the trade association for health insurance companies representing the industry’s top players, announced... Read More

More From Real Clear

The Latest Research from RealClear’s Journal of the Academy of Public Health
Article Image
Estimating the Importance of Change in Patient-Reported Outcome Measures
Patient-reported outcome measures (PROMs) are essential for capturing the patient’s perspective on their functioning and well-being...
Article Image
Restoring Regulatory Fairness and Reclaiming Biomedical Leadership: ALS, Rare Disease Regulation, and the Future of Regenerative Medicine
Amyotrophic Lateral Sclerosis (ALS) remains one of the most difficult neurodegenerative diseases in modern medicine. Despite major advanc...
These Are Where the Medicaid 'Cuts' Are Going.
The Value, Science, & Policies Surrounding Vaccines
What Doesn't Kill You ...
Was Trump's Operation Warp Speed a Success?

The Supreme Court

Abortion Deserves Sober Debate, not a War of Unreason

This is a difficult moment for Roe v. Wade to have fallen.... Read More

more from The Supreme Court

Public Health

We Must End the Public Health Emergency Carefully

If Congress and the administration do not plan and work together, the end of the old emergency will only mark the beginning of a new emergency.... Read More

more from Public Health

Health Care Reform

About That ObamaCare ‘Glitch’

The Affordable Care Act has faded into the political background since Republicans failed to repeal the entitlement in 2017, but ObamaCare still doesn't work as promised. The Biden Administration said this week that it will throw more money at one problem, and the result will be to hook more Americans on government subsidies.  ... Read More

Health Care Reform

Today's Topics

Copyright © RealClearHealth, LLC
© 2026 RealClearHealth | Go to full site